Allurion Technologies Inc (ALUR) USD0.0001

Sell:$6.20Buy:$6.45$0.07 (1.08%)

Prices delayed by at least 15 minutes
Sell:$6.20
Buy:$6.45
Change:$0.07 (1.08%)
Prices delayed by at least 15 minutes
Sell:$6.20
Buy:$6.45
Change:$0.07 (1.08%)
Prices delayed by at least 15 minutes

Company Information

About this company

Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform and health tracker devices. Its health tracker devices include Allurion Connected Scale and Allurion Health Tracker. Allurion Connected Scale offers a complete weight tracking experience, allowing users to monitor their weight, body mass index (BMI) and body composition. Allurion Health Tracker tracks steps, exercise and sleep. Allurion Virtual Care Suite is available to providers separately from the Allurion Program to help customize, monitor and manage weight-loss therapy for patients regardless of their treatment plan, which includes gastric balloon, surgical and medical or nutritional. Its Allurion Programme is offered in six months, 12 months and 12-18 months program.

Key people

Omar Syed Ishrak
Lead Independent Co-Chairman of the Board
Krishna K. Gupta
Independent Co-Chairman of the Board
Shantanu Gaur
Chief Executive Officer, Principal Financial Officer, Principal Accounting Officer, Director
Keith Johns
Director
R. Jason Richey
Director
Eli Lilly Veteran
Director
Milena Alberti-Perez
Independent Director
Michael Davin
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Technology
  • Industry
    Software & Programming
  • ISIN
    US02008G2012
  • Market cap
    $28.18m
  • Employees
    249
  • Shares in issue
    4.79m
  • Exchange
    New York Stock Exchange
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.